Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
99
100
Next >
S&P 500 Closes At Record High Ahead Of Inflation Data: Fear & Greed Index Remains In 'Neutral' Zone
July 09, 2024
The CNN Money Fear and Greed index slightly decreased, remaining in Neutral zone. US stocks mixed, with S&P 500 at record high.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
July 09, 2024
Eli Lilly and Co has emerged victorious in the weight loss drug competition, in a recent study. The study found that patients on Lilly's Mounjaro lost more weight than those on Novo Nordisk's Ozempic.
Via
Benzinga
Patients Lost More Weight On Eli Lilly's Mounjaro Than Novo Nordisk's Ozempic
July 08, 2024
Patients lost more more weight on Mounjaro than Ozempic.
Via
Investor's Business Daily
A $2.5 Trillion Opportunity In The Biotech Industry
July 08, 2024
In 1979, Genentech managed to create synthetic human insulin. Now 45 years later, biotech is a $1.77 trillion industry — up from $1.55 trillion in 2023. By 2030, that’s projected to reach close to $4...
Via
Talk Markets
Facebook Parent Meta Platforms Among 4 Hot Stocks At All-Time Highs: Look For The Best Stocks On These IBD Lists
July 08, 2024
Meta Platforms came aboard the Big Cap Leaders list, as did medical standout Eli Lilly. They were among four stock at all-time highs Monday.
Via
Investor's Business Daily
What's Going On With Eli Lilly Shares Friday?
July 05, 2024
Eli Lilly and Co. (NYSE: LLY) shares are experiencing increased activity Friday afternoon. Here's what you need to know.
Via
Benzinga
Smart Money Is Betting Big In LLY Options
July 05, 2024
Via
Benzinga
Gold Falls Over 1%; HilleVax Shares Plunge
July 08, 2024
Via
Benzinga
3 Overlooked Giants-in-the-Making for Patient Investors
July 08, 2024
Consider buying into these overlooked growth stocks for long-term profits that will help to boost a portfolio and deliver riches.
Via
InvestorPlace
Dow Turns Lower; Myomo Shares Jump
July 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stock Market News From Amazon, Nike, McCormick, and More
July 08, 2024
We also talk with author Nicola Twilley about her new book, "Frostbite: How Refrigeration Changed Our Food, Our Planet, and Ourselves."
Via
The Motley Fool
Here's How Much $100 Invested In Eli Lilly and Co 15 Years Ago Would Be Worth Today
July 04, 2024
Via
Benzinga
Why Is Morphic (MORF) Stock Up 75% Today?
July 08, 2024
Morphic stock is up on Monday after the company signed a deal with Eli Lilly for the acquisition of MORF shares at $57 each in cash.
Via
InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR)
July 08, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Eli Lilly's First Biotech Deal Of 2024, Buys Chronic Disease Player Morphic For $3.2B
July 08, 2024
Eli Lilly to acquire Morphic Holding Inc for $3.2 billion, strengthening its portfolio in chronic disease treatments. Morphic's lead program, MORF-057, targets inflammatory bowel disease, with...
Via
Benzinga
Eli Lilly Snaps Up Morphic At 79% Premium
July 08, 2024
Eli Lilly said Monday it would pay $3.2 billion to acquire an innovator in oral treatments for chronic bowel diseases.
Via
Investor's Business Daily
3 No-Brainer Stocks to Buy in July
July 08, 2024
Investors shouldn't have to think too hard about these great stocks.
Via
The Motley Fool
The Next $1 Trillion Stock? Tesla, Warren Buffett's Berkshire Hathaway In The Running
July 08, 2024
Tesla, Warren Buffett's Berkshire Hathaway are close, but this is No.1.
Via
Investor's Business Daily
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
The GLP-1 drug market for obesity treatment is expected to skyrocket to $1 trillion or more, according to Maurits Pot, founder and CEO of Tema ETFs.
Via
Benzinga
Topics
ETFs
The 7 Best Under $10 Stocks to Buy in July 2024
July 06, 2024
We’re finding big opportunities in some of the best stocks under $10 a share. In fact, here are seven you may want to jump into now.
Via
InvestorPlace
Copper, Gold Stocks Sparkle, Among 5 Leaders Near Buy Points
July 06, 2024
Southern Copper and Agnico Eagle surged above early entries.
Via
Investor's Business Daily
MarketBeat Week in Review – 7/1 - 7/5
July 06, 2024
The market was mostly quiet in a holiday-shortened week; that may change next week with the latest inflation readings and the kickoff of a new earnings season
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
GLP-1 Treatments Such As Wegvoy, Mounjaro Cut Obesity-Related Cancer Risks, Study Finds
July 05, 2024
A study finds that GLP-1 treatments, including Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, significantly reduce the risk of ten obesity-related cancers in type 2 diabetes patients, highlighting...
Via
Benzinga
Stock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review
July 05, 2024
However, small caps fell. Cooling economic data raised rate-cut hopes.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
July 05, 2024
A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.
Via
Investor's Business Daily
Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio
July 05, 2024
Could Zealand Pharma be a better option for growth-oriented investors?
Via
The Motley Fool
3 Highly Rated Biotech Stocks for Your July Buy List
July 05, 2024
Discover three top-rated biotech stocks that are pushing forward the pharma and biotech revolution on Wall Street.
Via
InvestorPlace
7 High Priced Stocks That Would Benefit From a Stock Split
July 04, 2024
These companies are prime stock split candidates following moves from Nvidia and Broadcom along with other big names.
Via
InvestorPlace
Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation
July 04, 2024
Investors shouldn't assume that all of the company's future growth is already priced into the stock's valuation.
Via
The Motley Fool
The 3 Best Healthcare Stocks to Buy in July 2024
July 04, 2024
Consistent breakthroughs, improved products and relatively consistent growth make these the best healthcare stocks to buy.
Via
InvestorPlace
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.